The transplantation of pancreatic islets for the treatment of type I diabetes is hindered by the enormous loss of cells due to early apoptotic events. Genetic engineering of islets with cytoprotective genes is an important strategy aimed to enhance the survival of these cells in the transplant setting. The present study was designed to evaluate and compare the effects of five genes on a cell line derived from insulin-producing β-cells, NIT-1. Cells were transduced using a Maloney murine leukemia virus (MLV) vector coding for yellow fluorescent protein (YFP) and for one of the following antiapoptotic genes: cFLIP, FADD-DN, BcL-2, PI-9, and ICAM-2. These genes were able to protect NIT-1 cells from cytokine-induced apoptosis to varying degrees ranging from no protection to significant protection equivalent to an optimal dose of a chemical caspase inhibitor. The data demonstrate that cFLIP, FADD-DN, and PI-9 are significantly more effective in protecting NIT-1 cells than BcL-2 and ICAM-2. Additionally, the data show that despite its weak in vitro inhibition of caspase-3, PI-9 affords significant protection against TNF-α-induced apoptosis in these cells. These genes may be ideal candidates to augment islet survival following transplantation.
AkaoM.; O'RourkeB.; KusuokaH.; TeshimaY.; JonesS. P.; MarbanE.Differential actions of cardioprotective agents on the mitochondrial death pathway.Circ. Res.92: 195–202; 2003.
2.
AnnandR. R.; DahlenJ. R.; SprecherC. A.; De DreuP.; FosterD. C.; MankovichJ. A.; TalanianR. V.; KisielW.; GiegelD. A.Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem.J.342(Pt. 3): 655–665; 1999.
3.
BadieB.; SchartnerJ.; VorpahlJ.; PrestonK.Interferon-gamma induces apoptosis and augments the expression of Fas and Fas ligand by microglia in vitro.Exp. Neurol.162: 290–296; 2000.
4.
BernasT.; DobruckiJ.Mitochondrial and nonmitochondrial reduction of MTT: Interaction of MTT with TMRE, JC-1, and NAO mitochondrial fluorescent probes.Cytometry47: 236–242; 2002.
5.
BianconeL.; RicordiC.Pancreatic islet transplantation: An update.Cell Transplant.11: 309–311; 2002.
6.
BiarnesM.; MontolioM.; NacherV.; RaurellM.; SolerJ.; MontanyaE.Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia.Diabetes51: 66–72; 2002.
7.
BirdC. H.; SuttonV. R.; SunJ.; HirstC. E.; NovakA.; KumarS.; TrapaniJ. A.; BirdP. I.Selective regulation of apoptosis: The cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway.Mol. Cell. Biol.18: 6387–6398; 1998.
8.
BoiseL. H.; GottschalkA. R.; QuintansJ.; ThompsonC. B.Bcl-2 and Bcl-2-related proteins in apoptosis regulation.Curr. Top. Microbiol. Immunol.200: 107–121; 1995.
9.
CattanP.; BerneyT.; SchenaS.; MolanoR. D.; PileggiA.; VizzardelliC.; RicordiC.; InverardiL.Early assessment of apoptosis in isolated islets of Langerhans.Transplantation71: 857–862; 2001.
10.
ChaoW.; ShenY.; LiL.; RosenzweigA.Importance of FADD signaling in serum-deprivation- and hypoxiainduced cardiomyocyte apoptosis.J. Biol. Chem.; 2002.
11.
ChinnaiyanA. M.; O'RourkeK.; TewariM.; DixitV. M.FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis.Cell81: 505–512; 1995.
12.
CottetS.; DuprazP.; HamburgerF.; DolciW.; JaquetM.; ThorensB.cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells.Diabetes51: 1805–1814; 2002.
13.
CottetS.; DuprazP.; HamburgerF.; DolciW.; JaquetM.; ThorensB.cFLIP protein prevents tumor necrosis factor-alpha-mediated induction of caspase-8-dependent apoptosis in insulin-secreting betaTc-Tet cells.Diabetes51: 1805–1814; 2002.
DahlenJ. R.; FosterD. C.; KisielW.Human proteinase inhibitor 9 (PI9) is a potent inhibitor of subtilisin A.Biochem. Biophys. Res. Commun.238: 329–333; 1997.
16.
DuprazP.; RinschC.; PralongW. F.; RollandE.; ZuffereyR.; TronoD.; ThorensB.Lentivirus-mediated Bcl-2 expression in betaTC-tet cells improves resistance to hypoxia and cytokine-induced apoptosis while preserving in vitro and in vivo control of insulin secretion.Gene Ther.6: 1160–1169; 1999.
17.
FlotteT.; AgarwalA.; WangJ.; SongS.; FenjvesE. S.; InverardiL.; ChesnutK.; AfioneS.; LoilerS.; WasserfallC.; KapturczakM.; EllisT.; NickH.; AtkinsonM.Efficient ex vivo transduction of pancreatic islet cells with recombinant adeno-associated virus vectors.Diabetes50: 515–520; 2001.
18.
GiannoukakisN.; MiZ.; GambottoA.; EramoA.; RicordiC.; TruccoM.; RobbinsP.Infection of intact human islets by a lentiviral vector.Gene Ther.6: 1545–1551; 1999.
19.
GiannoukakisN.; MiZ.; RudertW. A.; GambottoA.; TruccoM.; RobbinsP.Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I.Gene Ther.7(23): 2015–2022; 2000.
20.
HaraguchiM.; ToriiS.; MatsuzawaS.; XieZ.; KitadaS.; KrajewskiS.; YoshidaH.; MakT. W.; ReedJ. C.Apoptotic protease activating factor 1 (Apaf-1)-independent cell death suppression by Bcl-2. J. Exp.Med.191(10): 1709–1720; 2000.
21.
HeitmeierM. R.; ArnushM.; ScarimA. L.; CorbettJ. A.Pancreatic beta-cell damage mediated by beta-cell production of interleukin-1. A novel mechanism for virus-induced diabetes.J. Biol. Chem.276: 11151–11158; 2001.
22.
HuS.; VincenzC.; NiJ.; GentzR.; DixitV. M.I-FLICE, a novel inhibitor of tumor necrosis factor receptor-1- and CD-95-induced apoptosis.J. Biol. Chem.272: 17255–17257; 1997.
23.
IrmlerM.; ThomeM.; HahneM.; SchneiderP.; HofmannK.; SteinerV.; BodmerJ. L.; SchroterM.; BurnsK.; MattmannC.; RimoldiD.; FrenchL. E.; TschoppJ.Inhibition of death receptor signals by cellular FLIP.Nature388: 190–195; 1997.
24.
ItohK.; HaseH.; KojimaH.; SaotomeK.; NishiokaK.; KobataT.Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts.Rheumatology (Oxford); 2003.
25.
IwahashiH.; HanafusaT.; EguchiY.; NakajimaH.; MiyagawaJ.; ItohN.; TomitaK.; NambaM.; KuwajimaM.; NoguchiT.; TsujimotoY.; MatsuzawaY.Cytokine-induced apoptotic cell death in a mouse pancreatic beta-cell line: Inhibition by Bcl-2.Diabetologia39: 530–536; 1996.
KleinD.; RicordiC.; PuglieseA.; PastoriR. L.Inhibition of Fas-mediated apoptosis in mouse insulinoma betaTC-3 cells via an anti-Fas ribozyme.Hum. Gene Ther.11: 1033–1045; 2000.
28.
KronheimS. R.; MummaA.; GreenstreetT.; GlackinP. J.; Van NessK.; MarchC. J.; BlackR. A.Purification of interleukin-1 beta converting enzyme, the protease that cleaves the interleukin-1 beta precursor.Arch. Biochem. Biophys.296: 698–703; 1992.
29.
MedemaJ. P.; SchuurhuisD. H.; ReaD.; van TongerenJ.; de JongJ.; BresS. A.; LabanS.; ToesR. E.; ToebesM.; SchumacherT. N.; BladergroenB. A.; OssendorpF.; KummerJ. A.; MeliefC. J.; OffringaR.Expression of the serpin serine protease inhibitor 6 protects dendritic cells from cytotoxic T lymphocyte-induced apoptosis: Differential modulation by T helper type 1 and type 2 cells.J. Exp. Med.194: 657–667; 2001.
30.
PerezO. D.; KinoshitaS.; HitoshiY.; PayanD. G.; KitamuraT.; NolanG. P.; LorensJ. B.Activation of the PKB/AKT pathway by ICAM-2.Immunity16: 51–65; 2002.
31.
RabinovitchA.; Suarez-PinzonW.; StrynadkaK.; JuQ.; EdelsteinD.; BrownleeM.; KorbuttG. S.; RajotteR. V.Transfection of human pancreatic islets with an antiapoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction.Diabetes48: 1223–1229; 1999.
32.
RabinovitchA.; Suarez-PinzonW. L.; SorensenO.; BleackleyR. C.; PowerR. F.; RajotteR. V.Combined therapy with interleukin-4 and interleukin-10 inhibits autoimmune diabetes recurrence in syngeneic islet-transplanted nonobese diabetic mice. Analysis of cytokine mRNA expression in the graft.Transplantation60: 368–374; 1995.
33.
RathmellJ. C.; ThompsonC. B.The central effectors of cell death in the immune system.Annu. Rev. Immunol.17: 781–828; 1999.
34.
SarasteA.; PulkkiK.Morphologic and biochemical hallmarks of apoptosis.Cardiovasc. Res.45: 528–537; 2000.
35.
ScaffidiC.; SchmitzI.; ZhaJ.; KorsmeyerS. J.; KrammerP. H.; PeterM. E.Differential modulation of apoptosis sensitivity in CD95 type I and type II cells.J. Biol. Chem.274: 22532–22538; 1999.
36.
SchlapbachR.; SpanausK. S.; MalipieroU.; LensS.; TasinatoA.; TschoppJ.; FontanaA.TGF-beta induces the expression of the FLICE-inhibitory protein and inhibits Fas-mediated apoptosis of microglia.Eur. J. Immunol.30: 3680–3688; 2000.
37.
StrasserA.; NewtonK.FADD/MORT1, a signal transducer that can promote cell death or cell growth.Int. J. Biochem. Cell Biol.31: 533–537; 1999.
38.
ThornberryN. A.; BullH. G.; CalaycayJ. R.; ChapmanK. T.; HowardA. D.; KosturaM. J.; MillerD. K.; MolineauxS. M.; WeidnerJ. R.; AuninsJ.A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.Nature356: 768–774; 1992.
39.
WaterhouseN. J.; TrapaniJ. A.CTL: Caspases terminate life, but that's not the whole story.Tissue Antigens59: 175–183; 2002.
40.
WeaverM.; LeshleyK.; SandsH.; GritmanK. R.; LegosJ. J.; TumaR. F.LEX032, a novel recombinant serpin, protects the brain after transient focal ischemia.Microvasc. Res.63: 327–334; 2002.
41.
YehW. C.; ItieA.; EliaA. J.; NgM.; ShuH. B.; WakehamA.; MirtsosC.; SuzukiN.; BonnardM.; GoeddelD. V.; MakT. W.Requirement for casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development.Immunity12: 633–642; 2000.
42.
ZvibelI.; SmetsF.; SorianoH.Anoikis: Roadblock to cell transplantation?Cell Transplant.11: 621–630; 2002.
